Title |
Nitrates for acute heart failure syndromes
|
---|---|
Published in |
Cochrane database of systematic reviews, August 2013
|
DOI | 10.1002/14651858.cd005151.pub2 |
Pubmed ID | |
Authors |
Abel Wakai, Aileen McCabe, Rachel Kidney, Steven C Brooks, Rawle A Seupaul, Deborah B Diercks, Nigel Salter, Gregory J Fermann, Caroline Pospisil |
Abstract |
Current drug therapy for acute heart failure syndromes (AHFS) consists mainly of diuretics supplemented by vasodilators or inotropes. Nitrates have been used as vasodilators in AHFS for many years and have been shown to improve some aspects of AHFS in some small studies. The aim of this review was to determine the clinical efficacy and safety of nitrate vasodilators in AHFS. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 33% |
Spain | 1 | 33% |
Unknown | 1 | 33% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 33% |
Science communicators (journalists, bloggers, editors) | 1 | 33% |
Practitioners (doctors, other healthcare professionals) | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 250 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 2 | <1% |
Sweden | 1 | <1% |
Colombia | 1 | <1% |
Canada | 1 | <1% |
United States | 1 | <1% |
Unknown | 244 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 35 | 14% |
Student > Bachelor | 29 | 12% |
Researcher | 24 | 10% |
Student > Ph. D. Student | 24 | 10% |
Student > Postgraduate | 19 | 8% |
Other | 55 | 22% |
Unknown | 64 | 26% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 116 | 46% |
Nursing and Health Professions | 26 | 10% |
Psychology | 8 | 3% |
Biochemistry, Genetics and Molecular Biology | 4 | 2% |
Pharmacology, Toxicology and Pharmaceutical Science | 4 | 2% |
Other | 20 | 8% |
Unknown | 72 | 29% |
Attention Score in Context
This research output has an Altmetric Attention Score of 20. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 November 2023.
All research outputs
#1,915,312
of 25,806,763 outputs
Outputs from Cochrane database of systematic reviews
#4,076
of 13,140 outputs
Outputs of similar age
#15,848
of 209,851 outputs
Outputs of similar age from Cochrane database of systematic reviews
#89
of 250 outputs
Altmetric has tracked 25,806,763 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,140 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.9. This one has gotten more attention than average, scoring higher than 68% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 209,851 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 250 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.